Citations

Mayo Clinic

Showing 10 of 108551 citations.

Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia
Ahmed, Reham, Feldman, Andrew L. , Feldman, Andrew L

Blood | March 7, 2024 | Volume: 143 | Issue: 10 | Pages: 938-938

10.1182/blood.2023022971 | PMID 38451510 Get It

Primary Palliative Care in Urology: Quality Improvement Summit 2021-2022
Bergman, Jonathan , Calvert, Emily, Lorenz, Karl , Giannitrapani, Karleen F. , Koo, Kevin , Nielsen, Matthew E. , Filippou, Pauline L. , Suskind, Anne M. , Johnson, Karen , Fero, Katherine Elaine , Hugar, Lee A. , Leppert, John T. , Scales, Charles D. , Terris, Martha K. , Gore, John L.

Urology Practice | March 7, 2024 | Volume: 11 | Issue: 3 | Pages: 529-536

10.1097/upj.0000000000000538 | PMID 38451199 Get It

Letter to the Editor: Correlation of Spikes in Wastewater Severe Acute Respiratory Syndrome Coronavirus-2 Viral Load With Veno-Venous Extracorporeal Membrane Oxygenation Use for Coronavirus Disease 2019 in Minnesota
Evans, Danika, Wothe, Jillian K. , Dunn, Alex, Saavedra-Romero, Ramiro , Brunsvold, Melissa E. , Brunsvold, Melissa E , Bergman, Zachary , Bohman, J. Kyle , Prekker, Matthew E

Surgical Infections | March 7, 2024 | Volume: 25 | Issue: 3 | Pages: 255-256

10.1089/sur.2023.365 | PMID 38452181 Get It

Midlateral Approach Replantation of a Distal Phalanx Second Toe Amputation in a 4-Year-Old Child
Nishimura, Ken , KOBAYASHI, Koichi , Fukasawa, Katsuyasu , Sagedahl, Penn Derbyshire

JBJS Case Connector | March 7, 2024 | Volume: 14 | Issue: 1 | Pages: No page available

10.2106/jbjs.cc.23.00494 | PMID 38452157 Get It

Case: A 4-year-old girl patient presented with complete amputation of the second toe close to the distal interphalangeal joint. Replantation was performed using a novel midlateral approach. The procedure used the dorsal subcutaneous vein on the foot as a graft for the artery. Four months postoperatively, the toe healed without any complication. The patient reported pain-free physical exercise without limitations in daily activity. Conclusion: This report demonstrates that this approach has the potential to provide a safe and viable alternative for treating toe amputations and offers advantages such as simplified artery identification, straightforward anastomosis, and improved vein graft harvesting.
Infantile dural arteriovenous fistula: a reconsideration
Oushy, Soliman , Oushy, Soliman H , Orbach, Darren B.

Journal of NeuroInterventional Surgery | March 7, 2024 | Volume: 17 | Issue: 2 | Pages: 200-205

10.1136/jnis-2023-021355 | PMID 38453460 Get It

Background Infantile-type dural arteriovenous shunts (IDAVS) are rare and heterogeneous vascular lesions, complicating their classification and management. The current tripartite classification of pediatric dural arteriovenous shunts (DAVS) into dural sinus malformation, infantile-type, and adult-type, does not stand up to scrutiny, given the variable presentations of the latter two types in children. We estimate the prevalence of IDAVS and evaluate the long term outcomes after endovascular treatment (EVT). Methods A retrospective review of a pediatric cerebrovascular database between 2006 and 2023 was conducted. Clinical and radiographic data were analyzed to evaluate the presentation and long term outcomes of IDAVS. Results IDAVS were identified in 8 (0.5%) of 1463 patients, with mean age at diagnosis of 34.7 months; male infants comprised 62.5%. The most common clinical presentations included macrocephaly (37.5%), seizures (25%), and dilated scalp veins (25%). EVT was performed in 87.5% of cases, averaging 5.8 procedures per patient. Radiographic obliteration was observed in 28.6%. Good clinical outcomes (modified Rankin Scale score of ≤2) were achieved in 85.7%. Our findings showcased discrepancies and limitations in the current classification of pediatric DAVS, prompting a re-evaluation. Conclusion IDAVS accounted for a small proportion of pediatric cerebrovascular pathologies, with markedly heterogeneous presentations. Stepwise selective embolization was associated with favorable outcomes, and is recommended over an aggressive approach with the goal of complete angiographic obliteration. Our proposed revised classification system bifurcates pediatric DAVS into dural sinus malformations and all other DAVS that are manifest in children, thereby enhancing diagnostic clarity and therapeutic approaches.
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
Patnaik, Mrinal M. , Tefferi, Ayalew

American Journal of Hematology | March 7, 2024 | Volume: 99 | Issue: 6 | Pages: 1142-1165

10.1002/ajh.27271 | PMID 38450850 Get It

AbstractDisease OverviewChronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overlapping features of myelodysplastic syndromes and myeloproliferative neoplasms, characterized by prominent monocytosis and an inherent risk for leukemic transformation (~15%–20% over 3–5 years).DiagnosisNewly revised diagnostic criteria include sustained (>3 months) peripheral blood (PB) monocytosis (≥0.5 × 109/L; monocytes ≥10% of leukocyte count), consistent bone marrow (BM) morphology, <20% BM or PB blasts (including promonocytes), and cytogenetic or molecular evidence of clonality. Cytogenetic abnormalities occur in ~30% of patients, while >95% harbor somatic mutations: TET2 (~60%), SRSF2 (~50%), ASXL1 (~40%), RAS pathway (~30%), and others. The presence of ASXL1 and DNMT3A mutations and absence of TET2 mutations negatively impact overall survival (ASXL1WT/TET2MT genotype being favorable).Risk StratificationSeveral risk models serve similar purposes in identifying high‐risk patients that are considered for allogeneic stem cell transplant (ASCT) earlier than later. Risk factors in the Mayo Molecular Model (MMM) include presence of truncating ASXL1 mutations, absolute monocyte count >10 × 109/L, hemoglobin <10 g/dL, platelet count <100 × 109/L, and the presence of circulating immature myeloid cells; the resulting 4‐tiered risk categorization includes high (≥3 risk factors), intermediate‐2 (2 risk factors), intermediate‐1 (1 risk factor), and low (no risk factors); the corresponding median survivals were 16, 31, 59, and 97 months. CMML is also classified as being “myeloproliferative (MP‐CMML)” or “myelodysplastic (MD‐CMML),” based on the presence or absence of leukocyte count of ≥13 × 109/L.TreatmentASCT is the only treatment modality that secures cure or long‐term survival and is appropriate for MMM high/intermediate‐2 risk disease. Drug therapy is currently not disease‐modifying and includes hydroxyurea and hypomethylating agents; a recent phase‐3 study (DACOTA) comparing hydroxyurea and decitabine, in high‐risk MP‐CMML, showed similar overall survival at 23.1 versus 18.4 months, respectively, despite response rates being higher for decitabine (56% vs. 31%).Unique Disease AssociationsThese include systemic inflammatory autoimmune diseases, leukemia cutis and lysozyme‐induced nephropathy; the latter requires close monitoring of renal function during leukocytosis and is a potential indication for cytoreductive therapy.
Predicting posthospitalization falls in Brazilian older adults: External validation of the Carpenter instrument
Curiati, Pedro Kallas , Arruda, Marcela dos S., Carpenter, Christopher R. , Morinaga, Christian Valle , Melo, Hugo M. A., Aliberti, Marlon R., Curiati, Pedro K , Carpenter, Christopher R , Arruda, Marcela S, Avelino‐Silva, Thiago Junqueira , Aliberti, Márlon J R

Academic Emergency Medicine | March 7, 2024 | Volume: 31 | Issue: 7 | Pages: 688-695

10.1111/acem.14888 | PMID 38450932 Get It

AbstractObjectivesThis study sought to explore and externally validate the Carpenter instrument's efficacy in predicting postdischarge fall risk among older adults admitted to the emergency department (ED) for reasons other than falls or related injuries.MethodsA prospective cohort study was conducted on 779 patients aged ≥ 65 years from a tertiary hospital in São Paulo, Brazil, who were monitored for up to 6 months post‐ED hospitalization. The Carpenter instrument, which evaluates the four risk factors nonhealing foot sores, self‐reported depression, inability to self‐clip toenails, and prior falls, was utilized to assess fall risk. Follow‐up by telephone occurred at 30, 90, and 180 days to identify falls and mortality. Fine–Gray models estimated the predictive power of Carpenter instrument for future falls, considering death as a competing event and sociodemographic factors, frail status, and clinical measures as confounders.ResultsAmong 779 patients, 68 (9%) experienced a fall within 180 days post‐ED admission, and 88 (11%) died. The majority were male (54%), with a mean age of 79 years. Upon utilizing the Carpenter score, those with a higher fall risk (≥2 points) displayed more comorbidities, greater frailty, and increased clinical severity at baseline. Regression analyses showed that every additional point on the Carpenter score increased the hazard of falls by 73%. Two primary contributors to its predictive potential were identified: a history of falls in the preceding year and an inability to self‐clip toenails. However, the instrument's discriminative accuracy was suboptimal, with an area under the curve of 0.62.ConclusionsWhile the Carpenter instrument associated with a higher 6‐month postadmission fall risk among older adults post‐ED visit, its accuracy for individual patient decision making was limited. Given the significant impact of falls on health outcomes and health care costs, refining risk assessment tools remains essential. Future research should focus on enhancing these assessments and devising targeted proactive strategies.
Accurate, Robust, and Scalable Machine Abstraction of Mayo Endoscopic Subscores From Colonoscopy Reports
Silverman, Anna L. , Mosenia, Arman , Yasini, Fatema, Ramasamy, Gokul , Gupta, Saransh, Mardirossian, Taline, Narain, Rohan, Butte, Atul J. , Butte, Atul J , Rudrapatna, Vivek A , Silverman, Anna Lerman , Bhasuran, Balu , Banerjee, Imon , Sewell, Justin L.

Inflammatory Bowel Diseases | March 7, 2024 | Volume: 31 | Issue: 3 | Pages: 665-670

10.1093/ibd/izae068 | PMID 38533919 Get It

Abstract Background The Mayo endoscopic subscore (MES) is an important quantitative measure of disease activity in ulcerative colitis. Colonoscopy reports in routine clinical care usually characterize ulcerative colitis disease activity using free text description, limiting their utility for clinical research and quality improvement. We sought to develop algorithms to classify colonoscopy reports according to their MES. Methods We annotated 500 colonoscopy reports from 2 health systems. We trained and evaluated 4 classes of algorithms. Our primary outcome was accuracy in identifying scorable reports (binary) and assigning an MES (ordinal). Secondary outcomes included learning efficiency, generalizability, and fairness. Results Automated machine learning models achieved 98% and 97% accuracy on the binary and ordinal prediction tasks, outperforming other models. Binary models trained on the University of California, San Francisco data alone maintained accuracy (96%) on validation data from Zuckerberg San Francisco General. When using 80% of the training data, models remained accurate for the binary task (97% [n = 320]) but lost accuracy on the ordinal task (67% [n = 194]). We found no evidence of bias by gender (P = .65) or area deprivation index (P = .80). Conclusions We derived a highly accurate pair of models capable of classifying reports by their MES and recognizing when to abstain from prediction. Our models were generalizable on outside institution validation. There was no evidence of algorithmic bias. Our methods have the potential to enable retrospective studies of treatment effectiveness, prospective identification of patients meeting study criteria, and quality improvement efforts in inflammatory bowel diseases.
Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics
Sukniam, Kulkaew, Manaise, Harsheen Kaur, Popp, Kyle , Popp, Reed, Gabriel, Emmanuel , Gabriel, Emmanuel M

Cells | March 7, 2024 | Volume: 13 | Issue: 6 | Pages: 465

10.3390/cells13060465 | PMID 38534309 Get It

We aimed to review the molecular characteristics of metastatic melanoma and the role of surgery in metastasectomy for metastatic melanoma. We performed a systematic literature search on PubMed to identify relevant studies focusing on several mutations, including NRAS, BRAF, NF1, MITF, PTEN, TP53, CDKN2A, TERT, TMB, EGFR, and c-KIT. This was performed in the context of metastatic melanoma and the role of metastasectomy in the metastatic melanoma population. A comprehensive review of these molecular characteristics is presented with a focus on their prognosis and role in surgical metastasectomy.
Overexpression of SMYD3 Promotes Autosomal Dominant Polycystic Kidney Disease by Mediating Cell Proliferation and Genome Instability
Agborbesong, Ewud , Zhou, Julie , Zhang, Hongbing , Li, Xiaoyan , Harris, Peter C. , Calvet, James P. , Zhou, Julie Xia, Li, Linda Xiaoyan , Harris, Peter C , Calvet, James P , Li, Xiaogang

Biomedicines | March 7, 2024 | Volume: 12 | Issue: 3 | Pages: 603

10.3390/biomedicines12030603 | PMID 38540216 Get It

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder worldwide and progresses to end-stage renal disease (ESRD). However, its precise mechanism is not fully understood. In recent years, epigenetic reprogramming has drawn increasing attention regarding its effect on cyst growth. However, considering the complexity of epigenetic mechanisms and the broad range of alterations of epigenetic components in ADPKD, identifying more specific epigenetic factors and understanding how they are mechanistically linked to promote cyst growth is relevant for the development of treatment for ADPKD. Here, we find that the histone methyltransferase SMYD3, which activates gene transcription via histone H3 lysine 4 trimethylation (H3K4me3), is upregulated in PKD1 mutant mouse and human ADPKD kidneys. Genetic knockout of SMYD3 in a PKD1 knockout mouse model delayed cyst growth and improved kidney function compared with PKD1 single knockout mouse kidneys. Immunostaining and Western blot assays indicated that SMYD3 regulated PKD1-associated signaling pathways associated with proliferation, apoptosis, and cell cycle effectors in PKD1 mutant renal epithelial cells and tissues. In addition, we found that SMYD3 localized to the centrosome and regulated mitosis and cytokinesis via methylation of α-tubulin at lysine 40. In addition, SMYD3 regulated primary cilia assembly in PKD1 mutant mouse kidneys. In summary, our results demonstrate that overexpression of SMYD3 contributes to cyst progression and suggests targeting SMYD3 as a potential therapeutic strategy for ADPKD.